Friday, Mar 29, 2024
logo
Update At 14:00    USD/EUR 0,93  ↑+0.0012        USD/JPY 151,28  ↓-0.092        USD/KRW 1.345,82  ↓-1.53        EUR/JPY 163,01  ↓-0.269        Crude Oil 87,45  ↓-0.03        Asia Dow 3.834,45  ↓-17.48        TSE 1.818,50  ↓-3        Japan: Nikkei 225 40.331,16  ↑+163.09        S. Korea: KOSPI 2.747,98  ↑+2.16        China: Shanghai Composite 3.025,56  ↑+14.8994        Hong Kong: Hang Seng 16.541,42  ↑+148.58        Singapore: Straits Times 3,23  ↓-0.022        DJIA 22,79  ↑+0.04        Nasdaq Composite 16.379,46  ↓-20.063        S&P 500 5.254,35  ↑+5.86        Russell 2000 2.124,55  ↑+10.1984        Stoxx Euro 50 5.083,42  ↑+1.68        Stoxx Europe 600 512,67  ↑+0.92        Germany: DAX 18.492,49  ↑+15.4        UK: FTSE 100 7.952,62  ↑+20.64        Spain: IBEX 35 11.074,60  ↓-36.7        France: CAC 40 8.205,81  ↑+1        

The new pharma business model for Latin America

Article - December 5, 2011
Methabio is helping make Brasília a leader in pharmaceuticals
Brasilia’s location makes it one of the country’s logistical hubs, with regular international flights from Europe and North America bringing in pharmaceutical products. Brasilia also receives 80 percent of the flights connecting the South to the North of the country, allowing for a widespread distribution of the finished product.
Methabio is a Brazilian pharmaceutical company established in Brasilia that serves as a gateway for foreign companies wanting to invest and distribute within Brazil and Latin America. Working jointly with a customs precinct, ‘Porto Seco’ of Brasilia, Methabio is authorized to import, export and distribute all health-related products regulated by Anvisa (The National Health Surveillance Agency) and to operate as an industrial warehouse in Brazil.

Staikos Tzemos, President of Methabio says, “The great challenge in the pharmaceutical sector today is finding new ways of offering innovative services to get an edge, not directly in terms of price competitiveness but, rather, in the way the product is introduced into the country. For example, we have partners that can provide us with their product in bulk, rather than with the finished product, and we finish the product before taxes are applied. By doing so, we are not only able to cater to the Brazilian market, but to the whole of South America.”

Looking to the future, Methabio is now working in partnership with American companies to bring in products in the area of biologics. “My dream is to see Brasilia become a major capital with productive, servicing and selling capacity. I am sure we are on the right track,” says Mr. Tzemos.

  0 COMMENTS